Brief: Kineta Phase 1 Initial Data Readout Expected By End Of 2023
12/04/2023 11:38
April 12 (Reuters) - Kineta Inc KA.O :
* KINETA INC - PHASE 1 INITIAL DATA READOUT ANTICIPATED BY
END OF
2023
* KINETA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 CLINICAL
STUDY
OF KVA12123 FOR ADVANCED SOLID TUMORS
Source text for Eikon: ID:nGNX94bFDS
Further company coverage: KA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study